The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines
Open Access
- 1 November 2025
- journal article
- Published by University of Dayton Libraries in Oncology Rehabilitation in Practice
- Vol. 2 (2) , 47-55
Abstract
This article aims to provide a brief overview of the evidence and mechanisms for psilocybin use in EOL care. Additionally, this article will provide guidelines for clinicians to assess patient use and integrate psilocybin into their clinical practice with respect to its current legal status.Keywords
This publication has 32 references indexed in Scilit:
- Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic reviewJournal of Psychiatric Research, 2024
- Neuropathic pain, mood, and stress-related disorders: A literature review of comorbidity and co-pathogenesisNeuroscience & Biobehavioral Reviews, 2024
- Acute Adverse Effects of Therapeutic Doses of PsilocybinJAMA Network Open, 2024
- Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studiesEuropean Neuropsychopharmacology, 2023
- Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and PsilocybinACS Chemical Neuroscience, 2023
- Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic reviewPsychopharmacology, 2021
- Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug EffectsACS Pharmacology & Translational Science, 2021
- Suffering and distress at the end‐of‐lifePsycho-Oncology, 2011
- Existential Suffering in the Palliative Care Setting: An Integrated Literature ReviewJournal of Pain and Symptom Management, 2011
- Limitations of Pharmacotherapy: Behavioral Approaches to Chronic Pain2006